210 related articles for article (PubMed ID: 2971565)
1. Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease.
Lloberes P; Ramis L; Montserrat JM; Serra J; Campistol J; Picado C; Agusti-Vidal A
Eur Respir J; 1988 Jun; 1(6):536-9. PubMed ID: 2971565
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence.
Easton PA; Jadue C; Dhingra S; Anthonisen NR
N Engl J Med; 1986 Sep; 315(12):735-9. PubMed ID: 2943994
[TBL] [Abstract][Full Text] [Related]
3. Salbutamol and ipratropium bromide solution in the treatment of bronchospasm in asthmatic children.
Boner AL; De Stefano G; Niero E; Vallone G; Gaburro D
Ann Allergy; 1987 Jan; 58(1):54-8. PubMed ID: 2948430
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease.
Braun SR; McKenzie WN; Copeland C; Knight L; Ellersieck M
Arch Intern Med; 1989 Mar; 149(3):544-7. PubMed ID: 2521997
[TBL] [Abstract][Full Text] [Related]
5. Cumulative dose-response curves for assessing combined effects of salbutamol and ipratropium bromide in chronic asthma.
Grandordy BM; Thomas V; de Lauture D; Marsac J
Eur Respir J; 1988 Jun; 1(6):531-5. PubMed ID: 2971564
[TBL] [Abstract][Full Text] [Related]
6. Bronchodilators in patients with chronic obstructive pulmonary disease on mechanical ventilation. Utilization of metered-dose inhalers.
Fernandez A; Lazaro A; Garcia A; Aragon C; Cerda E
Am Rev Respir Dis; 1990 Jan; 141(1):164-8. PubMed ID: 2136979
[TBL] [Abstract][Full Text] [Related]
7. The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis.
Leitch AG; Hopkin JM; Ellis DA; Merchant S; McHardy GJ
Thorax; 1978 Dec; 33(6):711-3. PubMed ID: 154748
[TBL] [Abstract][Full Text] [Related]
8. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
Gross NJ; Petty TL; Friedman M; Skorodin MS; Silvers GW; Donohue JF
Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681
[TBL] [Abstract][Full Text] [Related]
9. Bronchodilatation and the site of airway resistance in severe chronic bronchitis.
Douglas NJ; Davidson I; Sudlow MF; Flenley DC
Thorax; 1979 Feb; 34(1):51-6. PubMed ID: 155891
[TBL] [Abstract][Full Text] [Related]
10. [Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].
Ginesu F; Ortu AR; Schena GP; Deiola G; Polo F
Arch Monaldi; 1983; 38(5-6):241-54. PubMed ID: 6238579
[No Abstract] [Full Text] [Related]
11. Clinical physiological data on the bronchodilator effect of Duovent versus salbutamol in chronic obstructive lung disease.
Marangio E; Pesci A; Mori A; Marchioni M; Bertorelli G
Respiration; 1986; 50 Suppl 2():165-8. PubMed ID: 2951798
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation.
Brown IG; Chan CS; Kelly CA; Dent AG; Zimmerman PV
Thorax; 1984 Apr; 39(4):272-6. PubMed ID: 6232724
[TBL] [Abstract][Full Text] [Related]
13. Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide.
Thiessen B; Pedersen OF
Respiration; 1982; 43(4):304-16. PubMed ID: 6213991
[TBL] [Abstract][Full Text] [Related]
14. [Use of aerosols in obstructive respiratory tract diseases. Clinical-pharmacological studies using fenoterol, salbutamol, ipratropium bromide and terbutaline].
Kaik G
Schweiz Med Wochenschr; 1977 Dec; 107(52):1948-57. PubMed ID: 145654
[TBL] [Abstract][Full Text] [Related]
15. A comparison of salbutamol and ipratropium in chronic bronchitis and chronic airflow limitation.
Barnes D; Delaney JC
Br J Clin Pract; 1988 Sep; 42(9):372-6. PubMed ID: 2978246
[No Abstract] [Full Text] [Related]
16. A comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solutions assessing dose-response and duration of action.
McIntosh D
Pharmatherapeutica; 1986; 4(7):416-21. PubMed ID: 2938194
[TBL] [Abstract][Full Text] [Related]
17. Comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solution assessing dose-response and duration of action.
McIntosh D
Respiration; 1986; 50 Suppl 2():310-2. PubMed ID: 2951827
[TBL] [Abstract][Full Text] [Related]
18. [Effect of vaporizing high doses of ipratropium bromide on lung ventilation in patients with chronic obstructive pulmonary disease and bronchial asthma].
Dor A; Krasnowska M; Małolepszy J
Pneumonol Alergol Pol; 1994; 62(1-2):75-9. PubMed ID: 8075617
[TBL] [Abstract][Full Text] [Related]
19. A dose response study comparing Duovent vs salbutamol.
Stewart DE; Gillies AJ
N Z Med J; 1987 Dec; 100(837):742-4. PubMed ID: 2967936
[TBL] [Abstract][Full Text] [Related]
20. Acute bronchodilator trials in chronic obstructive pulmonary disease.
Nisar M; Earis JE; Pearson MG; Calverley PM
Am Rev Respir Dis; 1992 Sep; 146(3):555-9. PubMed ID: 1387772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
